Nucleic Acid Testing Market: Future market projections for forthcoming years

Nucleic acid tests are performed in order to detect the presence of viral DNAs or RNAs in blood samples of patients. Three major processes involved in NAT are sample pooling and nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection.Major NAT technologies include polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and nucleic acid sequence based amplification (NASBA). Based on its major applications, NAT market can be classified into five major segments namely infectious diseases, genetic diseases, cancer, forensic testing and paternity testing.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/nucleic-acid-testing.html

Major growth drivers for the NAT market will include increasing prevalence of infectious diseases, cancer and genetic diseases, growing demand for technological advancements in testing methods, increasing end user acceptance and favorable regulatory mechanisms worldwide. It was estimated that approximately one billion people suffered from various infectious diseases worldwide in 2012, which is one of the major segments of the NAT market, thus will affect this markets growth in future. Growing demand for new and improved testing methods that utilizes new reagent systems and automated amplification systems in wide range of applications will also provide this market a larger share in the coming future.

Geographically, North America dominated the global NAT market with the largest share in terms of revenue, followed by the European region. Asia-Pacific is expected to be the fastest growing market in the coming future because in most of its countries, the NAT market is currently at nascent stage or underpenetrated. This region is likely to evolve under the influence of increasing awareness regarding the testing methods and continuously improving economic condition. The major players operating in the NAT market are Abbott Laboratories, Inc., Becton, Dickinson and Company, Beckman Coulter, Inc.,Bio-Rad Laboratories, Inc., Illumina, Inc., Siemens Healthcare, Gen-Probe, Inc., bioMérieux SA, Novartis AG, F. Hoffmann-La Roche Ltd., Sequenom, Inc.and Tecan Group Ltd.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1834

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=1834<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.